CLI-VEA-57525 BREAST CANCER ARTIFICIAL INTELLIGENCE
Utilising AI to support Pathologists in assessing and quantitating tumour markers when reporting breast cancer biopsies.
Buyer
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
Value
£163,448
Published
28 Oct 2024
Closes
28 Oct 2024
Procurement details
Source
Sell2Wales
Region
United Kingdom
Procurement method
Limited
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
48000000
Software package and information systems
Lots
Lot 1 CLI-VEA-57525 BREAST CANCER ARTIFICIAL INTELLIGENCE
£163,448
Utilising AI to support pathologists in the review of the slides, in identifying, grading and characterizing suspected findings of cancer in breast biopsy specimens and in filling slide- and case-level reports. The application also supports the pre-ordering of Breast tumour biomarkers based on the detection and characterization of Invasive breast cancer.
Delivery: Wales
Documents
Unlock document linkCLI-VEA-57525 BREAST CANCER ARTIFICIAL INTELLIGENCE
Not provided
Utilising AI to support Pathologists in assessing and quantitating tumour markers when reporting breast cancer biopsies.
Award notice · Web page
CLI-VEA-57525 BREAST CANCER ARTIFICIAL INTELLIGENCE
Not provided
Utilising AI to support Pathologists in assessing and quantitating tumour markers when reporting breast cancer biopsies.
Award notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.